Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by pidukson Jul 01, 2024 8:17am
108 Views
Post# 36113132

Looks like the CEO will have to explain weakening flower

Looks like the CEO will have to explain weakening flowerdemand in Germany.   Dave, 'you're an idiot' and no longer do companies in our country have to operate at the 'local' level or 'state laws' for pharmaceutical applications.  Extractors in California merely need to apply to the FDA for registration to supply cannabis extracts to the pharmaceutical industry.  

 Starting this Monday, Cannabis Social Clubs in Germany can officially apply to begin cultivation, marking a significant step since the legalization of cannabis consumption under certain conditions back in April.
 
According to NNN These clubs, organized to oversee the collective cultivation and distribution of cannabis among members, are now eligible to seek licenses for cultivation operations.  


<< Previous
Bullboard Posts
Next >>